Publication: The long term outcome of thirty eight post-transfusion hepatitis C
dc.contributor.author | Sompone Punyagupta | en_US |
dc.contributor.author | Taweeratana Siwadune | en_US |
dc.contributor.other | Vichaiyut Hospital | en_US |
dc.contributor.other | Mahidol University | en_US |
dc.date.accessioned | 2018-09-07T09:51:42Z | |
dc.date.available | 2018-09-07T09:51:42Z | |
dc.date.issued | 2001-01-01 | en_US |
dc.description.abstract | Thirty-eight cases of post-transfustion HCV hepatitis have been followed for 5-24 years. Cirrhosis and hepatocellular carcinoma were found in 44.7 per cent and 13.1 per cent respectively. Cirrhosis was recognised by pathological evidence as early as one and a half years after transfusion and the clinical evidences of decompensated cirrhosis were noted in the fifth year post-transfusion onward. Hepatocellular carcinoma was first recognised in year ten and thereafter. Nine patients died of liver failure or hepatocellular carcinoma during years 8-16 of the follow-up. Therefore, it is of utmost importance to screen out the HCV infected blood donors and to treat the HCV patients as early and as effectively as possible. | en_US |
dc.identifier.citation | Journal of the Medical Association of Thailand. Vol.84, No.1 (2001), 12-18 | en_US |
dc.identifier.issn | 01252208 | en_US |
dc.identifier.other | 2-s2.0-0035220903 | en_US |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/26878 | |
dc.rights | Mahidol University | en_US |
dc.rights.holder | SCOPUS | en_US |
dc.source.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035220903&origin=inward | en_US |
dc.subject | Medicine | en_US |
dc.title | The long term outcome of thirty eight post-transfusion hepatitis C | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication | |
mu.datasource.scopus | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0035220903&origin=inward | en_US |